Myopic Glaucoma
Conditions
Interventions
Two groups:Prostaglandin Analogs (PGA) and/or Carbonic anhydrase inhibitors (CAI) and/or Bromide and/or Selective Laser Trabeculoplasty (SLT) versus Travian (0.002%) once daily
Xalatan once daily
Azopt three times daily
Trusopt three times daily, 24 months
Sponsors
The Chinese University of Hong Kong
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Primary open angle glaucoma patients (POAG) who are: age =18 years; best corrected VA =20/40; POAG diagnosed within 12 months at the time of recruitment and receiving not more than one IOP-lowering medication.
Exclusion criteria
Exclusion criteria: POAG with IOP>30mmHg; advanced VF loss (VF MD <-18dB in the worse eye) or defects close to fixation (any one of the paracentral points with sensitivity <10dB); pathological myopia (eyes with axial length=26mm with lacquer cracks and chorioretinal atrophy); ocular or systemic diseases that may cause VF loss or optic disc abnormalities; inability to perform reliable VF; suboptimal quality of SDOCT images; previous intraocular surgery other than uncomplicated cataract extraction; and diabetic retinopathy/maculopathy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of eyes with VF progression; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of change of VF mean deviation (MD); | — |
Countries
China
Contacts
Public ContactDr. Leung Kai Shun Christopher
The Chinese University of Hong Kong
Outcome results
None listed